Junhao Yang
Stanford University
6 Papers
37 Citations
Junhao Yang is an academic researcher from Stanford University. The author has contributed to research in topics: Fusion protein & Antigen. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
Rapid expression of vaccine proteins for B‐cell lymphoma in a cell‐free system
Junhao Yang,Gregory Kanter,Alexei M. Voloshin,Nathalie Michel-Reydellet,Hendrik Velkeen,Ronald Levy,James R. Swartz +6 more
TL;DR: Four vaccine candidates were constructed by fusing murine GM-CSF to the amino- or carboxy-terminus of the 38C13 murine B-lymphocyte Id scFv with two different arrangements of the variable regions of the heavy chain and light chain, and between the two amino-terminal GM- CSF fusion proteins, GM-VL-VH showed a higher total and soluble yield than GM-Vh-VL.
92
Expression of active murine granulocyte-macrophage colony-stimulating factor in an Escherichia coli cell-free system.
TL;DR: The synthesis of a murine recombinant GM‐CSF in an E. coli cell‐free protein synthesis system with a high yield is reported and its cell‐proliferation activity was confirmed after purification with a Ni2+ chelating column.
50
Patent
Immunogenic Protein Constructs
James R. Swartz,Junhao Yang,Alexei M. Voloshin,Ronald Levy,Gregg Kanter,Shoshana Levy +5 more
- 14 Jan 2010
TL;DR: Bacterial immunity proteins are utilized to increase immune response to an antigen of interest as discussed by the authors, however, they do not have the ability to increase the immune response of the target antigen.
18
Patent
Fusion protein constructs
James R. Swartz,Junhao Yang,Alexei M. Voloshin +2 more
- 28 Jun 2007
TL;DR: Polypeptide linkers with defined tertiary structures, usually of defined alpha helical structure, are used to join two domains in a fusion protein this article, and a method is provided for the cell-free synthesis of the fusion protein.
18
A Novel Method for Producing Custom-Made Idiotype Vaccines for Lymphoma Immunotherapy Using a Cell-Free Expression System.
TL;DR: Data establish that a cell-free protein expression system can work for producing individualized idiotype vaccines for lymphoma, and three bi-weekly vaccinations with either fusion protein protected mice from tumor challenge with the syngeneic 38C13 tumor.
2